Brown, Lisle/Cummings’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.53K Buy
25
+23
+1,150% +$5.63K ﹤0.01% 663
2025
Q4
$507 Hold
2
﹤0.01% 721
2025
Q3
$495 Hold
2
﹤0.01% 743
2025
Q2
$480 Hold
2
﹤0.01% 753
2025
Q1
$453 Buy
+2
New +$440 ﹤0.01% 759

Other funds holding STE

Brown, Lisle/Cummings's STE Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Steris (STE) stake by 1,150% in Q1 2026, buying an estimated $5.63K and bringing the position to 25 shares worth $5.53K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Brown, Lisle/Cummings first reported a position in STE in Q1 2025 and has held it in 5 quarters since. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Brown, Lisle/Cummings held 25 shares of Steris worth $5.53K as of Q1 2026.
  • Brown, Lisle/Cummings bought 23 Steris shares in Q1 2026, an estimated $5.63K.
  • Steris made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #663 holding.
  • Brown, Lisle/Cummings first reported a position in Steris in Q1 2025 and has held it in 5 quarters since.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.